Furthermore, insulin resistance, a crucial metabolic marker associated with NAFLD progression, and high-sensitivity C-reactive protein (Hs-CRP), an essential indicator of systemic inflammation, were not assessed. The gene discussed is MAP3K14; the disease is metabolic dysfunction-associated steatotic liver disease.